Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component ...

Ribosomes are tiny molecular machines inside all living cells that build proteins, and ribosome biogenesis is the complex, ...

A more effective vaccine technology may be on the horizon. In a new study in mice, researchers from the University of Copenhagen demonstrate that a simple addition to mRNA vaccines can significantly ...

About Hanson Wade Group - 3rd mRNA Process Development & Manufacturing Europe The mRNA market is projected to reach $63.28 billion by 2025, indicating an all-time high global demand for mRNA ...

More information: Kosuke Fukuchi et al, Internal cap-initiated translation for efficient protein production from circular mRNA, Nature Biotechnology (2025). DOI: 10.1038/s41587-025-02561-8 ...

Researchers have discovered a process that breaks down mRNA molecules in the human body particularly efficiently. This could be useful, for example, in the treatment of cancer.

The COVID-19 vaccine from this sa-mRNA platform targeted against the JN.1 variant is approved in Japan for immunization against COVID-19 in adults 18 years and older and is being sold under the trade ...

3 rd Annual mRNA Process Development & Manufacturing Summit - members of Applied DNA's Biotherapeutics Sales and Business Development teams (collectively 'LineaRx,' a majority-owned Applied DNA ...